Reirradiation after radical radiation therapy: a survey of patterns of practice among Canadian radiation oncologists

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1523-9. doi: 10.1016/j.ijrobp.2008.03.048. Epub 2008 May 22.

Abstract

Purpose: The objective of this study was to survey the use of reirradiation (Re-RT) for in-field failures after previous radical radiation treatment (RT) among Canadian radiation oncologists (ROs).

Methods and materials: An electronic survey was sent to 271 ROs in Canada. The completed surveys were received electronically via e-mail and the data were analyzed using SAS 9.1.3 software.

Results: A total of 183 ROs (67.5%) completed and returned the survey. The majority of the respondents were involved in the practice of either breast (48%) or genitourinary (43%) tumor sites. A total of 49% of the participants were interested in using Re-RT for the management of in-field recurrences. The goals of the therapy would be improvement of quality of life (99%), locoregional control (80%), or cure (32%). Most of the physicians believed that patients should have a minimum Karnofsky performance status of 50 or Eastern Cooperative Oncology Group performance status of 3, a minimum life expectancy of 3 months, and a minimum interval from initial treatment of 3 months if Re-RT were to be given with curative intent.

Conclusions: This survey showed that a wide variation existed among ROs in their approach to Re-RT. Newer technologies in RT planning and delivery would be employed to facilitate normal tissue avoidance. The results of this study suggested that a consensus meeting was needed to establish guidelines for the practice and prospective evaluation of Re-RT.

MeSH terms

  • Age Factors
  • Breast Neoplasms / radiotherapy*
  • Canada
  • Disease-Free Survival
  • Electronics
  • Female
  • Health Surveys
  • Humans
  • Life Expectancy
  • Medicine
  • Neoplasm Staging
  • Patient Selection
  • Radiation Oncology / statistics & numerical data*
  • Radiotherapy / methods*
  • Retreatment / statistics & numerical data*
  • Software
  • Specialization
  • Surveys and Questionnaires
  • Urogenital Neoplasms / radiotherapy*